Blue Ash Therapeutics

United States
Cincinnati, Ohio, United States
(513) 554-0696 ★

Company profile

Blue Ash Therapeutics company profile

Blue Ash Therapeutics, LLC (BAT) is a privately funded company, formed in December 2008 in Cincinnati to bring a promising cardiovascular drug – azimilide - to market. BAT acquired the license for global development of azimilide dihydrochloride from Warner Chilcott in January 2010. After reactivating the azimilide IND, BAT formed a Cincinnati-based clinical and regulatory development team that met with the FDA and gained agreement, via the Special Protocol Assessment (SPA) process, for the design and sizing of a single Phase III trial as the final efficacy study needed for marketing approval. In April 2011 the azimilide license and global..... For more information, log in to dureach.com to view the full company profile.

Business identity

Contact email
[email protected]
Phone number
(513) 554-0696
Operating status
Active
Company type
For Profit
Employee range
00001-00010 employees
Revenue range
$1K+
Founded
2008-01-01

Headquarters

Headquarters
Cincinnati, Ohio, United States
Postal code
45246
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
1
Total equity funding
$1.6M
Last funding
Series A / $1.6M / 2010-04-23
Last equity funding
Series A / $1.6M
Investors
1

Categories and groups

Founders and investors

Investors

CincyTech

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.